Unichem Labs successfully completes USFDA inspection of Pithampur facility
"The United States Food and Drug Administration (USFDA) conducted an inspection at the Company's Pithampur, Active Pharmaceutical Ingredients (APIs) facility from September 2, 2019, to September 5, 2019," said Unichem in a filing.
Mumbai: Drug firm Unichem Laboratories recently said the US health regulator has concluded inspection of its Active Pharmaceutical Ingredients (APIs) facility in Pithampur without making any observations.
The inspection was a post-approval inspection and was conducted from September 2, 2019, to September 5, 2019. United States Food and Drug Administration (USFDA) successfully concluded the inspection without any FDA form 483 issued.
"The United States Food and Drug Administration (USFDA) conducted an inspection at the Company's Pithampur, Active Pharmaceutical Ingredients (APIs) facility from September 2, 2019, to September 5, 2019," said Unichem in a filing.
Read Also: Unichem gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder
Unichem Labs manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world. The Company has skills in product development, process chemistry and manufacturing complex API as well as dosage forms.
Read Also: Ghaziabad formulations facility gets 1 USFDA observation: Unichem Laboratories
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd